Conventional wisdom says that the scaffold in an important class of biological molecules called 'glycoconjugates' is essentially inert. Work by a chemist suggests otherwise. The discovery opens up new ...

Glycoconjugate vaccines can spur the body’s immune system to seek out and attack pathogens or cancer cells on the basis of which specific sugar chains decorate those targets. Approved vaccines for ...

The HIV-1 envelope, gp120, which features the binding determinants for both CD4 and coreceptor recognition, is key for virus entry and represents an attractive pharmacological target. However, ...

Researchers have created a vaccine that is more potent than traditional vaccines available today. The glycoconjugate vaccine prototype is 100 times more effective than traditional glycoconjugate ...

ITHACA, N.Y. -- Testing the efficacy of a vaccine candidate is typically a long process, with the immune response of an animal model taking around two months. A multi-institution team, led by Matt ...